These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28337662)
1. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Wu Y; Tran T; Dwabe S; Sarkissyan M; Kim J; Nava M; Clayton S; Pietras R; Farias-Eisner R; Vadgama JV Breast Cancer Res Treat; 2017 Jun; 163(3):449-460. PubMed ID: 28337662 [TBL] [Abstract][Full Text] [Related]
2. Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells. Wu Y; Ginther C; Kim J; Mosher N; Chung S; Slamon D; Vadgama JV Mol Cancer Res; 2012 Dec; 10(12):1597-606. PubMed ID: 23071104 [TBL] [Abstract][Full Text] [Related]
4. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. Thacker PC; Karunagaran D PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122 [TBL] [Abstract][Full Text] [Related]
5. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. Li J; Zhou BP BMC Cancer; 2011 Feb; 11():49. PubMed ID: 21284870 [TBL] [Abstract][Full Text] [Related]
6. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026 [TBL] [Abstract][Full Text] [Related]
7. Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway. Guo L; Peng W; Tao J; Lan Z; Hei H; Tian L; Pan W; Wang L; Zhang X PLoS One; 2016; 11(1):e0147018. PubMed ID: 26760502 [TBL] [Abstract][Full Text] [Related]
8. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells. Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892 [TBL] [Abstract][Full Text] [Related]
9. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
10. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway. Guo Y; Cui W; Pei Y; Xu D Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020 [TBL] [Abstract][Full Text] [Related]
11. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Yu J; Xie F; Bao X; Chen W; Xu Q Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626 [TBL] [Abstract][Full Text] [Related]
12. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478 [TBL] [Abstract][Full Text] [Related]
13. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment. Tian H; Liu J; Chen J; Gatza ML; Blobe GC Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021 [TBL] [Abstract][Full Text] [Related]
14. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465 [TBL] [Abstract][Full Text] [Related]
16. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition. Brown WS; Akhand SS; Wendt MK Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137 [TBL] [Abstract][Full Text] [Related]
17. The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). Chen Z; Zhang D; Yue F; Zheng M; Kovacevic Z; Richardson DR J Biol Chem; 2012 May; 287(21):17016-17028. PubMed ID: 22453918 [TBL] [Abstract][Full Text] [Related]
18. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway. Fan Q; Qiu MT; Zhu Z; Zhou JH; Chen L; Zhou Y; Gu W; Wang LH; Li ZN; Xu Y; Cheng WW; Wu D; Bao W Oncol Rep; 2015 Oct; 34(4):1787-94. PubMed ID: 26239019 [TBL] [Abstract][Full Text] [Related]
19. Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion. Liang YJ; Sun CP; Hsu YC; Chen YW; Wang IA; Su CW; Tao MH; Wu JC J Biomed Sci; 2020 May; 27(1):65. PubMed ID: 32434501 [TBL] [Abstract][Full Text] [Related]
20. LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells. Hu P; Yang J; Hou Y; Zhang H; Zeng Z; Zhao L; Yu T; Tang X; Tu G; Cui X; Liu M Cell Signal; 2014 Jan; 26(1):83-93. PubMed ID: 24113349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]